Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis

Medicine and Dentistry

• Ligand 62%
• Immunocompetent Cell 37%
• Organ 37%
• Atherosclerosis 37%
• Serositis 25%
• Hyperglycemia 25%
• Chronic Inflammation 25%
• Tissues 25%
• Receptor 12%
• Diseases 12%
• Monoclonal Antibody 12%
• Cell Type 12%
• Metabolite 12%
• In Vitro 12%
• Upregulation 12%
• Combination Therapy 12%
• Hyperlipidemia 12%
• Dyslipidemia 12%
• Immune System 12%
• Plaque 12%
• Water-Electrolyte Imbalance 12%
• Cell Activation 12%
• Apolipoprotein E 12%
• Cellular Stress Response 12%
• Aorta 12%
• Liver 12%
• Feedback System 12%

Immunology and Microbiology

• NKG2D 100%
• Inflammation 50%
• Atherosclerosis 37%
• Immunocompetent Cell 37%
• Organ 37%
• Mouse 25%
• Tissues 25%
• Immunity 25%
• Monoclonal Antibodies 12%
• Upregulation 12%
• Human 12%
• Cellular Stress Response 12%
• Immune System 12%
• Metabolite 12%
• Mouse Model 12%
• Cell Activation 12%
• Aorta 12%
• Liver 12%
• Reduction (Chemistry) 12%
• Feedback System 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Ligand 62%
• Atherosclerosis 37%
• Hyperglycemia 25%
• Mouse 25%
• Chronic Inflammation 25%
• Receptor 12%
• Diseases 12%
• Human 12%
• Monoclonal Antibody 12%
• Hyperlipidemia 12%
• Mouse Model 12%
• Dyslipidemia 12%
• Metabolic Disorder 12%
• Apolipoprotein E 12%